The Research and Development team at IconOVir is dedicated to advancing the company's pioneering oncolytic virus therapies through innovative scientific exploration and rigorous experimentation. Comprising a diverse group of scientists and advisors, the team collaborates to design and execute preclinical studies, analyze data, and translate findings into viable therapeutic strategies aimed at improving cancer treatment outcomes.
View all